What Orthopedic Executives Said About 2Q21 Executive Insights Industry Voices Second-quarter commentary from ortho executives focused on acquisitions, knee replacement sales performance and enabling technology’s impact. Aug 18, 2021
Medartis Advances Strategic Expansion in US Market Company Revenue The Numbers The company grew nearly 30% in the first half of 2021, with important contributions coming from its growing presence in the U.S. market. Aug 18, 2021
Amplitude Surgical Looks to Rebuild Momentum Company Revenue The Numbers The company closed its 2021 fiscal year up high single digits compared to 2020 but is still well below historical norms. Aug 16, 2021
Medacta Growth Spurred by New Products and Expanded Salesforce Company Revenue The Numbers The company reported more than 35% growth in the first half of 2021 with gains driven by new products and an expanded salesforce. Aug 13, 2021
Surgalign Beset by Problems with Legacy Business Company Revenue The Numbers The company improved in 2Q21 vs. last year but is dealing with regulatory and organization issues from the sale of its OEM business Aug 13, 2021
Conformis IP Buys Time for New Products Company Revenue The Numbers The company benefitted from $41 million in one-time royalty and settlement payments in 2Q21 but its product revenue remains down vs. 2019. Aug 11, 2021
OrthoPediatrics Organic Growth Driven by Market Share Gains Company Revenue The Numbers The company's revenue grew double-digits in 2Q21 on the strength of share gains instead of recapturing backlogged procedures. Aug 11, 2021
Anika Therapeutics Remains On Course In Transition Year Company Revenue The Numbers The company benefitted from improving COVID conditions in 2Q21 and remains on course to achieve both short and long-term strategic goals. Aug 10, 2021
Orthofix Benefits from New Products to Offset COVID Impact Company Revenue The Numbers In 2Q21, the company grew modestly compared to the same period in 2019 due to newer products like the M-6 disc and FITBONE. Aug 09, 2021
Vericel on Track for Robust Second Half in 2021 Company Revenue The Numbers The company outperformed expectations so far for 2021 and remains on track to realize growth in the 30% range for the full year. Aug 09, 2021